Dyadic to report 2021 year-end financial results on tuesday, march 29, 2022

Jupiter, fla., march 15, 2022 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on further improving, applying and deploying its proprietary c1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that it will report its financial results for 2021 year-end and host a corporate update conference call on tuesday, march 29, 2022.
DYAI Ratings Summary
DYAI Quant Ranking